We haya developed a rnicrocomputer based system with an application specific software packaga which perrnits the direct digitization and analysis of transrectal ultrasound (TRUS) images. The system is highly flexible and enables access to a wide range of image ana|ysis tools through relatively simple software modifications, which cannot be implernented using a standard ultrasound instrument. We haya dernonstrated the capability of the system by en anatysis of a nurnbar of morphometric pararneters and by a correletion of theae meaaurements with the presence of prostatic cencer. We found that the measurement of the ratio of the anterior-posterior axis to transversa axis and the presumed circular area ratio (PCAR) were significant predictors of prostatic cancer. The sensitivity of the PCAR measurement was 93%, the specificity was 50%, the positiva predictive value was 57%, and the negativa predictive value was 91%. The high negativa predictive values of theae parameters may provide objective criteria to allow for selectiva biopsy of patients. This system provides researchers with en efficient, economical, and flexible method to aid in the analysis of TRUS images in a quantitative manner. 9 1990 by W.B. Saunders Cornpany.
T
HE EVALUATION of the prostate gland is a major medical problem. Prostate carcinoma is the second leading cause of cancer deaths in males. Most recent estimates are that 28,000 men would die from prostate cancer in the United States in 1988 and that there would be approximately 99,000 new tases diagnosed.t Autopsy results indicate the prevalence of carcinoma may be as high as 15% to 40% of males older than 50 years of age. 2"3 In addition, it is estimated that as many as 80% of older males have benign prostatic hypertrophy. 4 The diseases of the prostate are age related, and the shifting demographics of this country to much older population insurcs that the numbers of patients with prostatic disease will be increasing in the future. Indeed, the trend of the incidence of prostate cancer as reported by the US National Center for Health Statistics has been increasing since 1960. 1 Success in the treatment of prostate carcinoma will no doubt increase because of early diagnosis. It is particularly important to detect the disease while it is operable and bcforc it metastasizes to other parts of the body. Occult prostatic cancer has no specific clinical indications. The use of biochemical markers to indicate the presence of prostate carcinoma has been evaluatedS; in particular, blood serum levels of prostatic specific antigen (PSA), acid phosphatase, and alkaline phosphatase have been measured and found to be elevated in patients with carcinoma of the prostate. Unfortunately, patients with benign prostatic hypertrophy also havr e|evated levels of these markers, which markedly decreases the specificity of the tests. This is especially true since the population needing screening the most has an extremely high incidence of benign prostatic hypertrophy (approaching 80%).
A malignancy may be suspected by the physician when the digital rectal exam reveals a palpable hard area. While it was once thought that the majority of prostatic cancers were located posteriorly in the region most accessible in a clinical examination, it has now been shown that this is not true. This was a false clinical impression since these were the cancers most commonly detected. McNeat ~ has shown that the cancer develops in all regions of the peripheral tissue with equal likelihood. The development of cancers in the lateral peripheral zone and transŸ tion zone ate anteriorly located and ate, therefore, more difficult to detect clinically. Alternative modes of diagnosis are clearly needed.
Evaluation of the prostate by ultrasound has been found to be very useful. While x-ray studies reveal little of the structures of the prostate, transrectal ultrasonagraphy produces excellent images of the prostate. The use of the transrectal ultrasound allows for the evaluation of all regions of the prostate. Studies indicate that use of the transrectal ultrasound allows for the detection of clinically significant cancers ata frequency about double that obtained by a physical exam alone. 7
Thus, the use of transrectal ultrasound in the evaluation of the prostate serves several roles including identifying nonpalpable tumors; staging known disease; directed biopsy of suspected tumors; directed placement of radioactive seeds for treatment; and determining glandular volume.
In order to improve the diagnostic accuracy and ease of interpreting transrectal ultrasound (TRUS) images, Kimura et al s defined some easily recognized features that could be quantitatively and objectively measured. These measurements were then used to predict the disease status of the patient. These geometrical parameters were chosen because of the long recognized characteristic changes that occur in prostatic cancer described by Watanabe et al 9 as early as 1976. These include changes in the anteriorposterior diameters, changes in the superiorinferior diameter, irregularity of transverse section shape, changes in section shape from level to level, and loss of symmetry. However, the measurement of these parameters is not conveniently accomplished with the current ultrasound units. Kimura et al 8 photographed TRUS images and used projected images on a digitizing board to obtain the measurements. This method is not feasible in usual practice.
We have developed an inexpensive hardware/ software system to enhance the utility and flexibility of the TRUS instrument. Our system consists of a dual buffered frame grab board which is connected directly to the ultrasound instrument, providing computer control over the images produced. Because software is more easily modified than hardware, our system allows for To demonstrate the added flexibility our system affords, we report here the development and testing of a software package to conveniently collect and organize a series of geometric measurements from prostatic ultrasound images. We then correlate these measurements with the diagnosis of prostatic cancer. The software package, PROST (Tucson, AZ), is designed to simplify the acquisition of geometric parameters characterizing the prostate gland, and to analyze that data in a fashion introduced by Kimura et al. 8
MATERIALS AND METHODS

Description of Hardware/Software System
We have developed an inexpensive computer operated system which allows for the direct acquisition and analysis of the images obtained with a TRUS. The system is based on an 80286 host microcomputer equipped with a Western Research Company, Inc, (Tucson, AZ) AST~ dual buffer video digitizer which interfaces directly with the ultrasound unit. The basic components of the system are shown schematically in Fig 1. Currently, the software allows for the acquisition of TRUS images in a format of 512 • 512 eight bit pixels. The interface board has sufficient memory for two such images and, by including the live image, ir is possible to work with three images simultaneously. The images may be saved to and recalled from hard disk storage. Two images may be compared using a blink comparator function which rapidly alternates between images. Image contrast can be enhanced in real time using a histogram stretch and slide algorithm. This capability is helpful in the delineation of the boundaries of the prostate in the images. We use a mouse to control the software in a point and seleet fashion. This typr of int•raction is one of the quickest and easiest types of interfaees to master; examples of menu selection options are shown in Fig 2. The most important featurr of PROST is that it enables the user to easily measure the geometrical paramr deseribed by Kimura el al. 8 The software maintains a data sheet for each patient whieh is automatieally filled in as the user makes the relevant measurements (Fig 3) . The user performs these measurements dire.r on the prostate image by using the mouse to direet a cursor. Once the user has marked the perimeter and two diameters of the prostate, the software automatically entera the measurements into the data sheet. The user can easily remeasure ifan error is made.
The software also keeps track of the images used and presenta them to the operator in a serial fashion corresponding to the correct anatomical progression of the 5 mm slices. Alternatively, the operator may request to view ah individual image.
In summary, this system provides a simple, e~cient, and easily learned method for obtaining quantitative measurements and for performing necessary calculations to analyze TRUS images. Furthermore, the system may be easily modified through simple software updates to include new types of measurements and new analysis methods.
Patients
We obtained our patient base from a population in a retirement oriented eommunity attending a private, single- F|g 2. Examples of menu bara from PROST, These main menu Ileler are preaented after being "pulled down'" under mouse control. serum titer. We deleted four of the patients from the data set, including one patient who had had a transurethral prostatectomy previously and had distorted prostate anatomy. The data sets of the other three patients were lost beeause of technical reasons.
TRUS Examination
Patients were routinely plaer in the lithotomy position anda Bruel & Kjaer (Marlborough, MA) endosonie probe, Type 1850 (7 MHz), was inserted rectaUy. The probe was attaehed to a stepping anit a,d withdrawn al 5 mm intervals. The ultrasound images al each leve1 were obtained using a BrucE & Kjaer Type 1846 ultrasound scanner.
At each level, we digitizr and stored the u[trasound image in a microcomputer equipped with a Western Research Company, Inc (Tucson, AZ) video digitizer and the PROST software paekage. The image aequisition procesa did not modify the routine evaluation of the patient and had no impact on the medical of surgieal treatment of the patient. We were able to analyze the images at a later convenient time.
We obtained at least three ultrasound-guided, needle biopsies from each prostate lobe (left and right). Our patient diagnosis is based on the histological examination of the biopsy.
Data Analysis
We analyzr the data using relative operating characteristic (ROC) techniques as desctibed by Beek and Shultz. ~o ROC analysis is a rapid, effective method to determine and compare the diagnostic utility of the measured parameters. The significante of the arca under the ROC curves (AUC) was determined by using the standard critical ratio test. We used the two-sample t test to caleulate signifieancr of the difference between the cantor and no-r162 group means+ The raw data for each patient were maintained in a dBase III (Culver C~ty, CA) data base, and we performed the analysis using a dBase command file designed to perform the ROC analysis and calcutate the z and t values+ The z values ate obtained for the standard eritical ratio test following the method of Beck and Shultz~~ these values ate used in a look-up tab]e to determine the assoeiated probability, p ( Table 2 and 3) .
RESULTS
The parameters used in the analysis by Kimura et al a were the anterior/posterior diameter, transverse diameter, and the perimeter of the prostate (Fig 4) . These parameters provide the basic geometrical information needed to evaluate the characteristic changes, noted by Watanabe et al 9 which occur with the prostatic cancer. From these values they calculated an asymmetry index (ASI), the anterior/posterior to transverse diameter ratio (ATR), a presumed circular arca ratio (PCAR), a section dissimilarity index (DSI), and the glandular weight. PCAR of only the largest section were used as parameters in the analysis. The DSI and weight were calculated using data from all sections.
The ASI is the maximum of the ratios of the halves of the transversa diameter (ie, maximum of AX/BX, or BX/AX as defined in Fig 4) . The PCAR is the actual area divided by the area of a circle which has a circumference equal to the measured slice perimeter. Shapes nearly circular have a PCAR approaching one. The DSI is a measure of variations in shape of consecutive sections. It is calculated as the sum of absoluta differences between the PCARs of adjacent sections weighted by the sum of the section areas; this causes the largar sections to contribute more to the DSI.
For each of the 34 patients in our study we determined these parameters, as well as the average PCAR, average ATR, and maximum ATR. The patients were assigned to either a caneer or no-eaneer category based upon the biopsy results. The average of the measured values in each category are shown in Table 1 . Also shown ate results of a two-sample t test that indicates the significance of a difference between the mean values for the two categories.
The age of the patient, PSA level, and PCAR were all significantly greater (>95% confidence level) in the patients with cancer. The ATR, which is closely related to the PCAR, was also highly significant (>92% confidence level). None of the other parameters were significantly different between the two groups. Figure 5 shows some representative ROC eurves obtained from our ROC analysis of the data. In this figure the greater the area under the ROC curve, the greater the ability of the test to indicate patients with cancer. An area under the curve of 0.5 is found with tests that have no predictive value and this curve is shown as a diagonal line in Fig 5. Clearly, the best results are obtained when the PSA level, PCAR, or ATR are considered. The other parameters are of no value in diagnosing the presence of prostate caneer.
The results of the ROC analysis are summarized in Table 2 . We performed the critical ratio test on each curve to test for a signi¡ difference from the value of 0.5 (ie, a test of no value). This analysis that the PSA, PCAR value, and the ATR value were all significantly different from the value of 0.5 at a significance greater than a 95% confidence level. The other values were not significantly different and were randomly associated with eancer in the prostate.
A pair-wise comparison of the area under the curves for different parameters was also performed, and these results indicate that curves for the ATR, PCAR, and PSA are statistically the same. This is in contrast to the comparison of the curves with, for example, the weight parameter which is statistically different (Table 3) . Therefore, these data suggest that the parameters of ATR, PCAR, and PSA are about equally efficacious in predicting the presence of prostatic eaneer.
We constructed a four cell predictive value matrix for the significant parameters, and the ealculated sensitivity, specificity, positive predictive value, and negative predictive value obtained are shown in Table 4 . Values of PSA greater than 4.3 ng per mi were considered abnormal. Inspection of the ROC curve for PCAR suggested that a cutoff of 0.75 would be close to optimal. Both the PSA and the PCAR measurement have high sensitivity (80% to 93%) but relatively low specificity (50%). The values we obtained for the serum PSA are very similar to those obtained by others. ]] The two parameters are not significantly different in their ability to distinguish patients with cancer. lnterestingly, both PSA and PCAR have strong negative prediction potential (83% to 91%). We have assumed that the two parameters (unlike PCAR and ATR) are unrelated. To determine ir the PCAR could maintain a strong negative predictive potential regardless of the PSA value, we divided the population into those with PSA values greater than or less than 4.3. We then determined the negative predictive value of the PCAR measurement in each subgroup. The results show that, indeed, the negative predietive value was high in both: 80% in the patients with elevated PSA levels and 100% in those with normal levels. (Table 4) . 
CONCLUSIONS
In this study, we have correlated morphological measurements from TRUS studies of the prostate gtand and serum PSA levels with the hŸ diagnosis from multiple biopsies of a group of high-risk pat[ents. Our results indieate that these measurements have significant diagnostic potential.
The morphological rneasurements we obtained were different in two major aspects eompared with the results obtained by Kirnura et al s First, we found no significant difference in weight between patients with or without prostate cancer. Second, we found that the PCAR was significantly larger in the eaneer patients and that it was highly correlated with the ATR (correlation coefficient of 0.994).
The reason for these differences is not known but rnay be partly due to the fact that we were dealing with an elderly population. Most of the pat… in our study had large prostates. On the other hand, the strong correlation between the ATR and the PCAR that we see is what we woutd expect frorn the geometrical relationship of the two parameters.
While the measurement of the PCAR or ATR eould be used asa sensitive screening test, the iow specificity of the measurement would result in a large number of false positive results. It is possible that the more usefut role of the PCAR measurement would be to utilize the negative predictive value of a measurement less than 0.75 to obviate the need to biopsy. This could potentially reduce the expense and morbidity of a prostate cancer screening program. The PCAR measurement may be partieularly useful in this role since it sectas to be independent of the serum PSA level. Therefore, it may be possible to avoid biopsy in some patients even if they have ah elevated PSA level. However, we will need to confirm these results with a larger group of patients before the role of morphological measurements in patient management can be defined. For this reason, we are eurrentty in the process of enlarging our patient database.
More recently, Hardeman et al t2 have reported on the value of the ATR measurement in staging of disease. This study included pathological staging and radical prostateetomy. They found that, of those tumors that involved both halves of the prostate and had penetrated the capsule, 71% had an ATR greater than 0.8. None of the tumors that were confined to the prostate had ah ATR greater than 0.8. While our study was not designed to address questions of staging, it [s interesting to note that norte of our patients had caneers that penetrated the eapsule and none had ah ATR greater than 0.8. This is consistent with the results of Hardeman et al. ]2
The major advantage of using the morphometric measurements is that they are quantitative and reproducible. They do not depend on the subjective analysis of the individual performing the exam. Furtherrnore, the measurernents are easy to perform and do not require highly trained personnel. The availability of this type of objective data could provide the basis for the development of expert systems to help physicians in the analysis of patients. The morphometric measurements may also help augment ultrasound studies of prostates that have isoeehoic lesions (possibly oecurring in as many as 37% of cases '2) .
We have demonstrated that images obtained from transrectal ultrasound studies can be easily and eeonomically captured in a digital formar. This enables eornputer-aided analysis of the information and provides flexibility to experirnent with a wide range of software applications. Researchers do not usually have this capability, since most transrectal ultrasound instruments do not have provisions for creating new measurement and analysis functions. The system we have described in this paper exemplifies the potential capabilities for developing new methodologies for analysis of the prostate gland.
From our experience we believe this system offers researchers the ability to manipulate ultrasound images in ah experimental fashion which may lead to improved diagnostic utility of TRUS. It also provides a means to maintain patient databases of TRUS images for future referenee. The images could be used for comparison with future studies, for example to determine if there is progression in lesions being treated pharmacologically. A prostate image database also provides opportunities to develop effective computeraided teaching and testing systems which could help train physicians to interpret TRUS images.
